Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.

Abstract:

:In Sarcoma 180 and L1210 ascites tumor models, the initial rate of methotrexate accumulation in tumor cells in the peritoneal cavity and in small intestine (intracellularly) after s.c. doses up to 800 mg/kg, showed saturation kinetics. These results and the fact that initial uptake in these tissues within this dosage range was inhibited to the expected relative extent by the simultaneous administration of leucovorin suggest that carrier mediation and not passive diffusion is the major route of drug entry at these extremely high doses. Maximum accumulation of intracellular drug occurred within 2 hr and reached much higher levels in small intestine than in tumor cells at the higher dosages. At a 3-mg/kg dose of methotrexate s.c., intracellular exchangeable drug levels persisted more than four times longer in L1210 cells than in small intestine, but differences in persistence (L1210 cell versus gut) diminished markedly with increasing dosage. At 96 mg/kg, the difference in persistence was less than 2-fold. In small intestine and L1210 cells, theduration of inhibition of DNA synthesis at different dosages correlated with the extent to which exchangeable drug was retained. Toxic deaths occurred when inhibition in small intestine lasted longer than 25 to 30 hr. Recovery of synthesis in small intestine and L1210 cells occurred synchronously and only below dosages of 400 mg/kg. Within 24 hr after dosages of greater than 24 mg/kg, the rate of tumor cell loss increased to a point characterized by a single exponential (t1/2=8.5 hr). The total cell loss, but not the rate of cell loss, was dose dependent.

journal_name

Cancer Res

journal_title

Cancer research

authors

Sirotnak FM,Donsbach RC,Dorick DM,Moccio DM

subject

Has Abstract

pub_date

1976-12-01 00:00:00

pages

4672-8

issue

12

eissn

0008-5472

issn

1538-7445

journal_volume

36

pub_type

杂志文章
  • Pathology, Chemoprevention, and Preclinical Models for Target Validation in Barrett Esophagus.

    abstract::Despite esophageal adenocarcinoma (EAC) being the most widespread among gastrointestinal cancers, with an 11-fold increase in the risk of cancer for patients with Barrett esophagus (BE), its prognosis is still poor. There is a critical need to better perceive the biology of cancer progression and identification of spe...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-0206

    authors: Urbanska AM,Ponnazhagan S,Mozafari M

    更新日期:2018-07-15 00:00:00

  • Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine.

    abstract::Experiments were performed to assess the role of liver cell necrosis in the induction of early steps in liver carcinogenesis with diethylnitrosamine, as measured by the appearance of foci of resistant hepatocytes that stain for gamma-glutamyl transpeptidase and that are presumptive preneoplastic lesions in the rat. Wi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ying TS,Sarma DS,Farber E

    更新日期:1981-06-01 00:00:00

  • Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo.

    abstract::Transforming growth factor beta (TGF-beta) is a potent growth-regulatory and immunomodulatory cytokine that exerts a diverse range of effects on many types of cells. High levels of TGF-beta are produced by several human and mouse malignant mesothelioma (MM) cell lines, and it is known to act as a growth factor for the...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Marzo AL,Fitzpatrick DR,Robinson BW,Scott B

    更新日期:1997-08-01 00:00:00

  • Efforts to control the errant products of a targeted in vivo generator.

    abstract::Alpha-particle immunotherapy by targeted alpha-emitters or alpha-emitting isotope generators is a novel form of extraordinarily potent cancer therapy. A major impediment to the clinical use of targeted actinium-225 (225Ac) in vivo generators may be the radiotoxicity of the systemically released daughter radionuclides....

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3096

    authors: Jaggi JS,Kappel BJ,McDevitt MR,Sgouros G,Flombaum CD,Cabassa C,Scheinberg DA

    更新日期:2005-06-01 00:00:00

  • Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin.

    abstract::Systemic chemotherapy generally has been considered immunosuppressive, but it has become evident that certain chemotherapeutic drugs elicit immunogenic danger signals in dying cancer cells that can incite protective antitumor immunity. In this study, we investigated whether locoregionally applied therapies, such as me...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-2089

    authors: Dudek-Perić AM,Ferreira GB,Muchowicz A,Wouters J,Prada N,Martin S,Kiviluoto S,Winiarska M,Boon L,Mathieu C,van den Oord J,Stas M,Gougeon ML,Golab J,Garg AD,Agostinis P

    更新日期:2015-04-15 00:00:00

  • Modification of host antitumor defense mechanisms in mice by progressively growing tumor.

    abstract::The EL4 lymphoma in C57BL/6 mice was used as a model to examine the effect of progressive tumor growth on a variety of cell mediated cytolytic effector functions which have been shown in other systems to have antitumor potential. The functions examined were those of cytolytic T-lymphocyte, lymphokine activated killer ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Maccubbin DL,Mace KF,Ehrke MJ,Mihich E

    更新日期:1989-08-01 00:00:00

  • O6-benzylguanine: a clinical trial establishing the biochemical modulatory dose in tumor tissue for alkyltransferase-directed DNA repair.

    abstract::Early phase evaluation of anticancer drugs has traditionally used toxicity (usually hematological) rather than efficacy end points to establish appropriate dosing schedules. To establish a biochemical efficacy end point for overcoming alkylguanine DNA alkyltransferase (AGT)-mediated tumor cell resistance to 1,3-bis(2-...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Spiro TP,Gerson SL,Liu L,Majka S,Haaga J,Hoppel CL,Ingalls ST,Pluda JM,Willson JK

    更新日期:1999-05-15 00:00:00

  • Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro.

    abstract::Fludarabine (9-beta-arabinofuranosyl-2-fluoroadenine-5'-monophosphate) is clinically active against chronic lymphocytic leukemia and low-grade lymphomas. We reported previously that fludarabine nucleoside synergistically enhanced cisplatin (CDDP)-induced cytotoxicity in vitro, and that the synergism was concomitant wi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Li L,Liu X,Glassman AB,Keating MJ,Stros M,Plunkett W,Yang LY

    更新日期:1997-04-15 00:00:00

  • The von Hippel-Lindau tumor suppressor targets to mitochondria.

    abstract::Subcellular localization of von Hippel-Lindau (VHL) tumor suppressor may clarify its role in tumorigenesis. In rat kidney, we observed a granular cytoplasmic immunostaining of VHL, as seen in human tissues. The green fluorescent protein (GFP)-tagged VHL also appeared as cytoplasmic granules in vitro and was colocalize...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shiao YH,Resau JH,Nagashima K,Anderson LM,Ramakrishna G

    更新日期:2000-06-01 00:00:00

  • CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.

    abstract::Although significant advances in radiotherapy have increased its effectiveness in many cancer settings, general strategies to widen the therapeutic window between normal tissue toxicity and malignant tumor destruction would still offer great value. CD47 blockade has been found to confer radioprotection to normal tissu...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-0037-T

    authors: Soto-Pantoja DR,Terabe M,Ghosh A,Ridnour LA,DeGraff WG,Wink DA,Berzofsky JA,Roberts DD

    更新日期:2014-12-01 00:00:00

  • Nitric oxide in physiologic concentrations targets the translational machinery to increase the proliferation of human breast cancer cells: involvement of mammalian target of rapamycin/eIF4E pathway.

    abstract::Nitric oxide (NO) in nanomolar (nmol/L) concentrations is consistently detected in tumor microenvironment and has been found to promote tumorigenesis. The mechanism by which NO enhances tumor progression is largely unknown. In this study, we investigated the possible mechanisms and identified cellular targets by which...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-4623

    authors: Pervin S,Singh R,Hernandez E,Wu G,Chaudhuri G

    更新日期:2007-01-01 00:00:00

  • CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.

    abstract::The role of CD4+ T lymphocytes in antitumor immunity has been largely attributed to providing signals required for the priming of MHC class I-restricted CD8+ cytotoxic T lymphocytes, and CD8+ cytotoxic T lymphocytes are thought to serve as the predominant mediators of tumor killing in vivo. We decided to evaluate the ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kennedy RC,Shearer MH,Watts AM,Bright RK

    更新日期:2003-03-01 00:00:00

  • Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.

    abstract::Infection by human T-cell leukemia virus type (HTLV) I leads to adult T-cell leukemia and is also associated with the neurodegenerative disease HTLV-I-associated myelopathy/tropical spastic paraparesis. Leukocytes are attracted to sites of inflammation by chemokines. One such chemokine is monocyte chemoattractant prot...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Mori N,Ueda A,Ikeda S,Yamasaki Y,Yamada Y,Tomonaga M,Morikawa S,Geleziunas R,Yoshimura T,Yamamoto N

    更新日期:2000-09-01 00:00:00

  • In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

    abstract::The insulin-like growth factor receptor (IGF-IR) and insulin receptor are either overactivated and/or overexpressed in a wide range of tumor types and contribute to tumorigenicity, proliferation, metastasis, and drug resistance. Here, we show that BMS-554417, a novel small molecule developed as an inhibitor of IGF-IR,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1107

    authors: Haluska P,Carboni JM,Loegering DA,Lee FY,Wittman M,Saulnier MG,Frennesson DB,Kalli KR,Conover CA,Attar RM,Kaufmann SH,Gottardis M,Erlichman C

    更新日期:2006-01-01 00:00:00

  • Transcriptional control of estrogen receptor in estrogen receptor-negative breast carcinoma.

    abstract::The mechanisms which control estrogen receptor (ER) expression in breast carcinoma have not been elucidated. The MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) breast carcinoma cell lines have been used to examine ER gene expression. Northern blot analysis of mRNA isolated from these two cell lines demonstrates that...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Weigel RJ,deConinck EC

    更新日期:1993-08-01 00:00:00

  • In vivo flow cytometry: a new method for enumerating circulating cancer cells.

    abstract::The fate of circulating tumor cells is an important determinant of their ability to form distant metastasis. Here, we demonstrate the use of in vivo flow cytometry as a powerful new method for detecting quantitatively circulating cancer cells. We specifically examine the circulation kinetics of two prostate cancer cel...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-1058

    authors: Georgakoudi I,Solban N,Novak J,Rice WL,Wei X,Hasan T,Lin CP

    更新日期:2004-08-01 00:00:00

  • Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.

    abstract::We have examined the effects of protein kinase C (PK-C) stimulation and cytosolic Ca2+ elevation on the in vitro induction of non-histocompatibility-restricted tumoricidal activity from human peripheral blood lymphocytes. The tumor cytolytic activity, as well as the number of cells recovered from interleukin 2 (IL-2)-...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: McCrady CW,Li F,Grant AJ,Merchant RE,Carchman RA

    更新日期:1988-02-01 00:00:00

  • Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells.

    abstract::Toll-like receptor (TLR) agonists are considered adjuvants in clinical trials of cancer immunotherapy. Here, we investigated the modulation of gammadelta T cell-mediated tumor cell lysis by TLR ligands. gammadelta T-cell cytotoxicity and granzyme A/B production were enhanced after pretreatment of tumor cells with TLR3...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1602

    authors: Shojaei H,Oberg HH,Juricke M,Marischen L,Kunz M,Mundhenke C,Gieseler F,Kabelitz D,Wesch D

    更新日期:2009-11-15 00:00:00

  • Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas.

    abstract::To identify genetic alterations underlying rectal carcinogenesis, we used global gene expression profiling of a series of 17 locally advanced rectal adenocarcinomas and 20 normal rectal mucosa biopsies on oligonucleotide arrays. A total of 351 genes were differentially expressed (P < 1.0e-7) between normal rectal muco...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-2533

    authors: Grade M,Ghadimi BM,Varma S,Simon R,Wangsa D,Barenboim-Stapleton L,Liersch T,Becker H,Ried T,Difilippantonio MJ

    更新日期:2006-01-01 00:00:00

  • STK33 kinase activity is nonessential in KRAS-dependent cancer cells.

    abstract::Despite the prevalence of KRAS mutations in human cancers, there remain no targeted therapies for treatment. The serine-threonine kinase STK33 has been proposed to be required for the survival of mutant KRAS-dependent cell lines, suggesting that small molecule kinase inhibitors of STK33 may be useful to treat KRAS-dep...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-0778

    authors: Babij C,Zhang Y,Kurzeja RJ,Munzli A,Shehabeldin A,Fernando M,Quon K,Kassner PD,Ruefli-Brasse AA,Watson VJ,Fajardo F,Jackson A,Zondlo J,Sun Y,Ellison AR,Plewa CA,San MT,Robinson J,McCarter J,Schwandner R,Judd T,C

    更新日期:2011-09-01 00:00:00

  • Imaging techniques for the radioimmunodetection of cancer.

    abstract::Problems in the radioimmunodetection of cancer typically involve small lesions having low object contrast. As such, the imaging device utilized must have a high spatial resolution as well as high detection efficiency. In addition, the imaging device must be interfaced to a computer system to allow data manipulation to...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rollo FD,Patton JA

    更新日期:1980-08-01 00:00:00

  • A new anticancer glycolipid monoclonal antibody, SC104, which directly induces tumor cell apoptosis.

    abstract::A novel monoclonal antibody was raised by immunization of mice with colorectal tumor cell lines. The fusion was screened by immunohistochemistry for binding to primary colorectal tumors. Subsequent analysis on primary disaggregated colorectal tumors show that the antibody recognizes a cell surface antigen expressed by...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-3812

    authors: Durrant LG,Harding SJ,Green NH,Buckberry LD,Parsons T

    更新日期:2006-06-01 00:00:00

  • Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.

    abstract::Rhabdomyosarcoma (RMS) is a common soft-tissue sarcoma of childhood in need of more effective therapeutic options. The expression of p53 in RMS is heterogeneous such that some tumors are wild-type whereas others are p53 mutant. The small molecule CP-31398 modulates both the wild-type and the mutant p53 proteins. Here,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0942

    authors: Xu J,Timares L,Heilpern C,Weng Z,Li C,Xu H,Pressey JG,Elmets CA,Kopelovich L,Athar M

    更新日期:2010-08-15 00:00:00

  • Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.

    abstract::A significant impediment to the success of cancer chemotherapy is multidrug resistance (MDR). A typical form of MDR is attributable to the overexpression of membrane transport proteins, such as P-glycoprotein, resulting in an increased drug efflux. In this study, we show that adenovirus-mediated enhancement of the c-J...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1779

    authors: Zhou J,Liu M,Aneja R,Chandra R,Lage H,Joshi HC

    更新日期:2006-01-01 00:00:00

  • Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.

    abstract::The bryostatins are a group of macrocyclic lactones isolated from the marine bryozoan Bugula neritina. Bryostatin 1, like the phorbol esters, activates protein kinase C; however, it partially inhibits the phorbol ester induced differentiation of the human promyelocytic leukemic cell line HL-60. We compared the phospho...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Warren BS,Kamano Y,Pettit GR,Blumberg PM

    更新日期:1988-11-01 00:00:00

  • Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer.

    abstract::We have recently identified a new gene, interleukin-17 receptor-like (IL-17RL), which is expressed in normal prostate and prostate cancer. This investigation is focused on the role of IL-17RL in prostate cancer. We found that IL-17RL was expressed at significantly higher levels in several androgen-independent prostate...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1130

    authors: You Z,Shi XB,DuRaine G,Haudenschild D,Tepper CG,Lo SH,Gandour-Edwards R,de Vere White RW,Reddi AH

    更新日期:2006-01-01 00:00:00

  • Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote tumor cell motility and metastasis.

    abstract::Nm23-H1 has been identified as a metastasis suppressor gene, but its protein interactions have yet to be understood with any mechanistic clarity. In this study, we evaluated the proteomic spectrum of interactions made by Nm23-H1 in 4T1 murine breast cancer cells derived from tissue culture, primary mammary tumors, and...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0368

    authors: Marino N,Marshall JC,Collins JW,Zhou M,Qian Y,Veenstra T,Steeg PS

    更新日期:2013-10-01 00:00:00

  • Alteration of gene expression in normal-appearing colon mucosa of APC(min) mice and human cancer patients.

    abstract::The expression of many genes is altered in colon cancer, but the roles of these genes in carcinogenesis are unclear. Using real-time quantitative PCR, we demonstrated that several genes previously implicated in human colon cancer undergo altered expression in the APC(min) mouse adenomatous polyp, a precursor of cancer...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-03-3264

    authors: Chen LC,Hao CY,Chiu YS,Wong P,Melnick JS,Brotman M,Moretto J,Mendes F,Smith AP,Bennington JL,Moore D,Lee NM

    更新日期:2004-05-15 00:00:00

  • Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother.

    abstract::This review portrays an updated overview about the possible tumor suppressive properties of the Rb2/p130 gene, the third member of the retinoblastoma (RB) family of genes, including RB itself and p107. After a brief analysis of the established structural and functional similarities among the three genes, the main purp...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Paggi MG,Giordano A

    更新日期:2001-06-15 00:00:00

  • Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency.

    abstract::Type 2 diabetes, which is mainly linked to obesity, is associated with increased incidence of liver cancer. We have previously found that in various models of obesity/diabetes, hyperinsulinemia maintains heightened hepatic expression of cyclin D1, suggesting a plausible mechanism linking diabetes and liver cancer prog...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-20-0106

    authors: Luo C,Liang J,Sharabi K,Hatting M,Perry EA,Tavares CDJ,Goyal L,Srivastava A,Bilodeau M,Zhu AX,Sicinski P,Puigserver P

    更新日期:2020-08-15 00:00:00